Astec LifeSciences Limited reported unaudited consolidated and standalone earnings results for the first quarter ended June 30, 2016. For the quarter, on standalone basis, the company reported net sales/income from operations (net of excise duty) of INR 643.471 million compared to INR 566.533 million a year ago. Profit from operations before other income, interest & exceptional items was INR 79.938 million compared to INR 103.258 million a year ago. Profit from ordinary activities before tax was INR 50.909 million compared to INR 70.430 million a year ago. Net profit was INR 37.388 million or INR 1.92 per basic and diluted share before and after extra ordinary items compared to INR 55.076 million or INR 2.83 per basic and diluted share before and after extra ordinary items for the last year. For the quarter, on consolidated basis, the company reported net sales/income from operations (net of excise duty) of INR 643.471 million compared to INR 593.615 million a year ago. Profit from operations before other income, interest & exceptional items was INR 80.179 million compared to INR 105.086 million a year ago. Profit from ordinary activities before tax was INR 51.150 million compared to INR 67.643 million a year ago. Net profit was INR 37.554 million or INR 1.92 per diluted share before and after extra ordinary items compared to INR 51.739 million or INR 2.66 per basic and diluted share before and after extra ordinary items for the last year.